Hello LongeCity community,I wanted to start a discussion about the emerging research on GLP-1 receptor agonists (like Semaglutide and Tirzepatide) and their potential implications for longevity beyond just weight management.Recent studies are suggesting these medications may have broader anti-aging effects:1. Reduced systemic inflammation - chronic inflammation is a key driver of aging2. Improved insulin sensitivity - metabolic dysfunction accelerates biological aging3. Cardiovascular protection - heart disease remains a leading cause of mortality4. Potential neuroprotective effects - some research shows reduced cognitive decline riskWhat's particularly interesting is how these benefits seem to connect metabolic health directly to the aging process. The "inflammaging" hypothesis suggests that metabolic dysfunction and chronic low-grade inflammation are central to many age-related diseases.I've been reading educational resources at www.glunovabio.com about the science behind these peptide therapies and how they work at the cellular level.For those following GLP-1 research:- Do you see these medications as potential longevity interventions?- How do they compare to other anti-aging strategies like NAD+ supplementation or rapamycin?- Are there any long-term studies on lifespan extension you're aware of?Would love to hear perspectives from this knowledgeable community!
